)
ImpediMed (IPD) investor relations material
ImpediMed EGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Chair welcomed shareholders, acknowledged traditional land owners, and confirmed quorum for the meeting.
Directors and executives were introduced, both in-person and online.
Purpose of the meeting was to seek shareholder approval for all elements of a AUD 15.2 million capital raising.
Specific resolutions to be voted on
Ratification of tranche one placement shares and approval for tranche one options.
Approval for tranche two securities and share purchase plan (SPP) securities.
Approval to issue commitment options to the underwriter.
Approval to issue director placement securities for each director.
Strategic initiatives and plans
Capital raised will partially prepay debt, saving AUD 0.7 million in annual interest.
Funds to be deployed into high-growth markets: breast cancer-related lymphedema, heart health, and weight management.
Cost base reset with AUD 5 million in annualized cost reductions, net of reinvestment in revenue-generating functions.
Expectation to reach operating cash flow breakeven by second half of FY2028, assuming full exercise of options.
- Revenue up 25% to $7.5M, with strong recurring growth and expanded US reimbursement.IPD
H1 20263 Jun 2026 - SOZO Core Business and ARR grew 14% and 18% despite a 9% revenue drop, with break-even targeted by July 2025.IPD
H2 20243 Jun 2026 - $15.2M equity raise funds SOZO®-driven US expansion, targeting FY28 cashflow breakeven.IPD
Investor presentation4 May 2026 - A$15.2 million capital raise and cost cuts set a path to breakeven by FY28.IPD
Trading update4 May 2026 - Q3 FY26 revenue reached $3.5M, with expanded US reimbursement and new CEO appointed.IPD
Q3 202629 Apr 2026 - New CEO appointed to drive U.S. growth as Q3 shows solid sales and ongoing cost discipline.IPD
Investor update7 Apr 2026 - Q2 revenue hit $3.9M, ARR $14.4M, BCRL coverage 92.8%, SOZO Pro launched, 6.5 quarters funding.IPD
Q2 20263 Feb 2026 - Q4 revenue up 10%, leads and US sales surged, cash strong, and break-even targeted in two years.IPD
Q4 2024 TU2 Feb 2026 - TCV up 40% to A$4.8M, ARR at A$11.6M, pipeline and coverage expand, cash outflows to fall.IPD
Q1 2025 TU19 Jan 2026
Next ImpediMed earnings date
Next ImpediMed earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)